Result DFS in 8 cases of patients with acute myelogenous leukemia received Mixed-HSCT and treated with DLI +IL-2 for 2-7 times were 62.5%. There were no GVHD.

• 经过1~5年观察；8例患者Mixed-HSCT后应用DLI+IL-2治疗的患者长期生存率为62.；5%25。